An examination of β‐cell function measures and their potential use for estimating β‐cell mass
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
A characteristic and dominant feature of type 2 diabetes is a reduction in β‐cell function that is associated with a decrease in β‐cell volume. A decline in the first‐phase insulin response following intravenous glucose administration can be demonstrated as the fasting glucose concentration increases. This response is completely absent before the glucose threshold that defines diabetes has been reached and at a time when β‐cells are clearly still present, implying that a functional β‐cell lesion has to exist independent of β‐cell loss. Surgical or chemical reductions of up to 65% of β‐cell volume demonstrate that functional adaptation of the normal β‐cell prevents a rise in fasting glucose or reduction in first‐phase insulin response. However, the ability of glucose to potentiate the β‐cell’s response to non‐glucose secretagogues is reduced and is more closely associated with the reduction in β‐cell volume. The future, in terms of prevention and treatment of type 2 diabetes, lies in the ability to prevent and revert both β‐cell loss and dysfunction. However, until β‐cell volume can be quantified reliably and non‐invasively, we will need to rely on the ability of glucose to potentiate insulin release as the best surrogate estimate of the number of β‐cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Immunoassay of endogenous plasma insulin in man
Yalow, R. S., & Berson, S. A. (1960) · Journal of Clinical Investigation · doi:10.1172/jci104130 · Cited by 3,041
The biology of incretin hormones
Drucker, D. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.004 · Cited by 2,210
Kahn, S. E., Prigeon, R. L., McCulloch, D. K., Boyko, E. J., Bergman, R. N., Schwartz, M. W., Neifing, J. L., Ward, W. K., Beard, J. C., & Palmer, J. P. (1993) · Diabetes · doi:10.2337/diab.42.11.1663 · Cited by 1,405
Self-citationMolecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young
Fajans, S. S., Bell, G. I., & Polonsky, K. S. (2001) · New England Journal of Medicine · doi:10.1056/nejmra002168 · Cited by 1,123
Glucolipotoxicity: fuel excess and β-cell dysfunction
Poitout, V., & Robertson, R. P. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0023 · Cited by 1,092
Bagdade, J. D., Bierman, E. L., & Porte, D. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105646 · Cited by 672
Mitrakou, A., Kelley, D., Mokan, M., Veneman, T., Pangburn, T., Reilly, J., & Gerich, J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201023260104 · Cited by 595
Ferrannini, E., Gastaldelli, A., Miyazaki, Y., Matsuda, M., Mari, A., & DeFronzo, R. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1133 · Cited by 540
Impaired Pulsatile Secretion of Insulin in Relatives of Patients with Non-Insulin-Dependent Diabetes
O'Rahilly, S., Turner, R. C., & Matthews, D. R. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805123181902 · Cited by 540
Cited by
Depression and type 2 diabetes: A causal association?
Tabák, A. G., Akbaraly, T. N., Batty, G. D., & Kivimäki, M. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70139-6 · Cited by 167
Rickels, M. R., Liu, C., Shlansky-Goldberg, R. D., Soleimanpour, S. A., Vivek, K., Kamoun, M., Min, Z., Markmann, E., Palangian, M., Dalton-Bakes, C., et al. (2013) · Diabetes · doi:10.2337/db12-1802 · Cited by 103
Woerle, H. J., Carneiro, L., Derani, A., Göke, B., & Schirra, J. (2012) · Diabetes · doi:10.2337/db11-1701 · Cited by 73
Metadata
- Authors
- Kahn, S. E., Carr, D. B., Faulenbach, M. V., & Utzschneider, K. M.
- Venue
- Diabetes, Obesity and Metabolism
- Publisher
- Wiley
- Published
- 2008-10-02
- Volume
- 10
- Issue
- s4
- Pages
- 63-76
- ISSN
- 1462-8902 (ISSN-L)
- 1463-1326
- OpenAlex
- W2014676695
- Cited by
- 60
- References
- 32
- FWCI
- 4.85
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An examination of β‐cell function measures and their potential use for estimating β‐cell mass. https://app.cochat.ai/papers/10.1111/j.1463-1326.2008.00945.x
- The paper
- Kahn, S. E., Carr, D. B., Faulenbach, M. V., & Utzschneider, K. M. (2008). An examination of β‐cell function measures and their potential use for estimating β‐cell mass. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/j.1463-1326.2008.00945.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.